"The technology is about 96 percent sensitive on recognizing skin cancer, and with the dermatologist follow-up it’s even at a higher level," said Erik de Heus, CEO at SkinVision. "Our service isn’t a replacement of a dermatologist; it’s a complementary service.’’
We’re super excited to hear more about this real-world application of AI, that has more than a million users around the world and has impacted the health systems in Australia, UK and the Netherlands by already spotting 27,000 dangerous melanomas.
We can’t wait to hear from you Erik! Join Erik de Heus and the global AI healthcare community at Intelligent Health in Basel this September.
Intelligent Health AI
11th-12th September 2019
Basel Congress Center, Switzerland